Development and Characterization of 3D Organoid Lines from Circulating Tumor Cells of African-American Prostate Cancer Patients
Development and Characterization of 3D Organoid Lines from Circulating Tumor Cells of African-American Prostate Cancer Patients
批准号:
9273217
负责人:
Gagan Deep
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-07-15 至 2018-06-30
关键词:
African AmericanAgeAnabolismAreaAttentionB-LymphocytesBiogenesisBiologicalBiological AssayCancer EtiologyCancer PatientCaucasiansCell LineCell ProliferationCell SurvivalCellsDevelopmentDiagnosisDiseaseEmployee StrikesEndothelial CellsEpigenetic ProcessExhibitsFibroblastsFormalinGeneticGleason Grade for Prostate CancerHealthHypoxiaLactic acidMalignant NeoplasmsMalignant neoplasm of prostateMass Spectrum AnalysisMeasuresMediatingMetabolicMolecularMorbidity - disease rateNeoplasm Circulating CellsNon-MalignantOrganoidsOutcomeOxygenPatientsPhenotypeProstateProstatectomyProteinsPublic HealthRoleSerumSignal PathwaySocioeconomic StatusSurvival RateTestingTubeTumor Tissueexosomehealth disparityhigh risk menknock-downmacrophagemenmortalitynanoparticlenew therapeutic targetoutcome forecastprostate cancer cellracial disparityresearch studytumor microenvironment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Prostate cancer (PCA) exhibits the most striking racial disparity as African American men are at higher risk of being diagnosed and dying of PCA, in comparison with Caucasian men. Although, multiple factors including socio-economic status contribute to this disparity but it is essential to identify the molecular and underlying biological differences that contribute to the more aggressive phenotype in African American PCA. There have been several studies investigating the genetic and epigenetic differences between African American and Caucasian PCA; however in the past, limited attention has been given to the role of tumor microenvironment contributing towards disease aggressiveness in African American PCA. In this regard, our preliminary studies discovered a unique capability of African American PCA cells to survive under hypoxic (low oxygen condition) conditions dependent upon cellular RAB5A expression, the master regulator of exosomes biogenesis, as the survival of African American PCA cells was completely compromised in RAB5A knock-down condition. More importantly, compared to Caucasian PCA cells, African American PCA cells secreted significantly higher amount of exosomes under hypoxic conditions. Interestingly, African American PCA cells seem to better adapt to hypoxia through exporting metabolic product lactic acid packaged in exosomes. Recent studies have also provided ample evidence that lactic acid is used not only as a fuel for bioenergy and biosynthesis but lactic acid also activates several mitogenic signaling pathways in various tumor microenvironment cellular components including endothelial cells, fibroblasts, macrophages and PCA cells in the normoxic areas. Taken together, we hypothesize that "African American PCA cells have the unique capability to survive hypoxia via RAB5A-mediated exosomes secretion loaded with lactic acid, and the secreted exosomes promote extensive tumor microenvironment remodeling and disease aggressiveness'. Following specific aims are proposed to test our hypothesis: (I) to characterize and establish RAB5A role in exosomes secretion and survival of African American PCA cells under hypoxia; and (II) to examine and establish the role of exosomes secreted by African American PCA cells in tumor microenvironment remodeling. Proposed studies will bring a paradigm shift in our approach to understand and treat PCA in African American men brining greater focus on tumor microenvironment both for prognosis as well as treatment purposes. Overall, present proposal is highly significant and will help to narrow the huge health disparity gap faced by African American PCA patients, and reduce the PCA-caused mortality and morbidity in these patients.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2741/4565
发表时间:
2017-06-01
期刊:
Frontiers in bioscience (Landmark edition)
影响因子:
--
作者:
[]
通讯作者:
DOI:
10.18632/oncotarget.24532
发表时间:
2018-03-02
期刊:
Oncotarget
影响因子:
--
作者:
[Panigrahi GK, Ramteke A, Birks D, Abouzeid Ali HE, Venkataraman S, Agarwal C, Vibhakar R, Miller LD, Agarwal R, Abd Elmageed ZY, Deep G]
通讯作者:
Deep G
DOI:
10.1038/s41598-018-34637-8
发表时间:
2018-11-05
期刊:
Scientific reports
影响因子:
4.6
作者:
[Ali HEA, Lung PY, Sholl AB, Gad SA, Bustamante JJ, Ali HI, Rhim JS, Deep G, Zhang J, Abd Elmageed ZY]
通讯作者:
Abd Elmageed ZY
DOI:
10.1615/critrevoncog.v20.i5-6.130
发表时间:
2015
期刊:
Critical reviews in oncogenesis
影响因子:
--
作者:
[Deep G, Panigrahi GK]
通讯作者:
Panigrahi GK
A unique exosome-based approach to identify novel biomarkers for Alzheimer's disease
-
批准号:10354433
-
项目类别:
-
资助金额:$42.63万
-
财政年份:2022
-
负责人:Gagan Deep
-
依托单位:
Multi-Ethnic Study of Atherosclerosis- Cellular Exosomes in Neurodegeneration and Dementia (MESA-CEND)
-
批准号:10301683
-
项目类别:
-
资助金额:$229.56万
-
财政年份:2021
-
负责人:Gagan Deep
-
依托单位:
MESA-CEND: Promoting diversity in Alzheimer’s disease research
-
批准号:10598345
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2021
-
负责人:Gagan Deep
-
依托单位:
Neuronal exosomes in cocaine abuse and treatment response in socially housed monkeys
-
批准号:10393515
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2019
-
负责人:Gagan Deep
-
依托单位:
Neuronal exosomes in cocaine abuse and treatment response in socially housed monkeys
-
批准号:10609495
-
项目类别:
-
资助金额:$38.75万
-
财政年份:2019
-
负责人:Gagan Deep
-
依托单位:
Exosomes Promote Disease aggressiveness in African American Prostate Cancer
-
批准号:8974158
-
项目类别:
-
资助金额:$5.26万
-
财政年份:2015
-
负责人:Gagan Deep
-
依托单位:
Exosomes Promote Disease Aggressiveness in African American Prostate Cancer
-
批准号:9272480
-
项目类别:
-
资助金额:$15.03万
-
财政年份:2015
-
负责人:Gagan Deep
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: